Skip to main content

Table 1 Demographics and preoperative data

From: High thoracic anesthesia offers no major benefit over general anesthesia in on-pump cardiac surgery patients: a retrospective study

 

GA, n = 141

TEA, n = 147

P value

EUROSCORE II

3.5 ± 3.8

3.65 ± 3.64

0.694

Age (years)

66.9 ± 10.9

64.3 ± 9.8

0.041

Height (meters)

1.70 ± 0.09

1.71 ± 0.09

0.137

Weight (kilograms)

80.5 ± 16.3

82.9 ± 17

0.104

BSA (m2)

1.91 ± 0.20

1.96 ± 0.21

0.064

BMI (kg/m2)

27.8 ± 4.5

28.4 ± 5.5

0.395

Male (female)

94 (47)

99 (48)

0.902

CAD

82 (58.2 %)

76 (51.7 %)

0.066

Arterial hypertension

114 (80.9 %)

109 (74.1 %)

0.208

LV EF (%)

54.4 ± 12.6

56.8 ± 11.2

0.044

RV dysfunction

14 (9.9 %)

15 (10.2 %)

0.996

COPD

32 (22.7 %)

40 (27.2 %)

0.295

Diabetes mellitus

27 (19.1 %)

38 (25.9 %)

0.832

Stroke/TIA

15 (10.6 %)

16 (10.9 %)

0.946

NYHA

  

0.370

 I

10 (7.1 %)

14 (9.5 %)

 

 II

76 (53.9 %)

83 (56.5 %)

 

 III

52 (36.9 %)

46 (31.3 %)

 

 IV

3 (2.1 %)

4 (2.7 %)

 

Serum creatinine (µmol/L)

91.6 ± 27.4

94.4 ± 35.7

0.999

  1. EUROSCORE II European System for Cardiac Operative Risk Evaluation II, BSA body surface area, BMI body mass index, CAD coronary artery disease, LV EF left ventricular ejection fraction, RV right ventricular, COPD chronic obstructive pulmonary disease (FEV1 ˂80 %, FEV1/FVC˂70 %), TIA transitory ischemic attack, NYHA New York Heart Association heart failure classification
  2. Italic values indicate significance value of P < 0.05